CBE
CBE (Centre for Biopharmaceutical Excellence) is a Melbourne-based specialist consulting firm delivering partner-led GMP, regulatory, due diligence, facility design, and workforce training services to biopharmaceutical, pharmaceutical, and medical technology companies across the Asia Pacific region.
- Company typePrivate
- Founded2014
- HeadquartersMelbourne, Australia
- Headcount1–10
- GTM typeB2B
- OfferingServices
What CBE does
CBE (Centre for Biopharmaceutical Excellence), operating as CBE Pty Ltd, is an Australia-based specialist consulting firm serving the biopharmaceutical, pharmaceutical, and medical technology sectors across the Asia Pacific region. Founded in 2014 and headquartered at the Jumar Bioincubator in Melbourne, the firm delivers partner-led advisory services across the full product lifecycle — including GxP compliance and audits, regulatory and clinical submissions, due diligence, product and process robustness, facility concept and cleanroom design, and consulting operations and strategy. All engagements are delivered directly by senior Partners or Associates rather than junior staff, drawing on decades of operating experience at companies such as Pfizer/Hospira, CSL, and Seqirus.
CBE supplements its consulting practice with a structured training portfolio comprising the Essential GMP Uplift and Advanced GMP Uplift programs (delivered in partnership with the MTPConnect REDI initiative funded by the Australian Medical Research Future Fund), a Translation Uplift program covering R&D-to-commercial scale-up, and tailored training for universities, enterprises, and industry associations. Training is delivered through a mix of online platforms (LearnWorlds), hands-on workshops at partner GMP-like facilities (CBE Pure Solutions in Melbourne, TRI T3 Cleanrooms in Brisbane, UTS Biologics Innovation Facility in Sydney), and bespoke enterprise programs — including government-underwritten CPD programs for the Hong Kong pharmaceutical industry via HKPMA and academic delivery for the Chinese University of Hong Kong.
The firm monetises exclusively through professional services (consulting fees and training program revenue), with pricing on a quote-based, non-publicly-disclosed basis. The go-to-market motion is sales-led and direct, supported by conference presence (ISPE, ARCS Australia, AusBiotech, BioMelbourne Network), industry-association partnerships, and an informative content website. CBE serves a distributed client base spanning large biopharma manufacturers, biotech startups, academic research institutes, and non-profits, with 85+ companies having completed its GMP Uplift programs. Geographic reach extends across Australia, New Zealand, Hong Kong, China, Thailand, Singapore, Indonesia, and Korea.
CBE firmographics
Firmographics- Name
- CBE
- Legal name
- CBE Pty Ltd
- Website
- https://cbe-ap.com.au
- Company type
- Private
- Founded year
- 2014
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- CBE (Centre for Biopharmaceutical Excellence) is a Melbourne-based specialist consulting firm delivering partner-led GMP, regulatory, due diligence, facility design, and workforce training services to biopharmaceutical, pharmaceutical, and medical technology companies across the Asia Pacific region.
- Ownership category
- akta.pro rank
CBE industry classification
Industry- Product category
- Biopharmaceutical Consulting Services
- NAICS
- Management Consulting Services (54161), Other Management Consulting Services (541618), Management, Scientific, and Technical Consulting Services (5416)
- SIC
- Services-Management Consulting Services (8742), Services-Educational Services (8200), Services-Engineering, Accounting, Research, Management (8700)
- akta.pro primary industry
- Training & Competency Programs for GxP Compliance (HLAGAKAM)
- akta.pro secondary industries
- CMC, Process Development & Tech Transfer Staffing FSP (HLAGAOAK), Learning, Training & Corporate Education Consulting (BPAHAGAE), Healthcare Clinical Professions (CME/CE for Nurses, Allied Health, Pharmacy) (EDAAALAC)
Keywords
Where CBE is headquartered
LocationHeadquarters
- HQ city
- Melbourne
- HQ country
- Australia
- HQ region
- Oceania
Offices5 records
Markets served
CBE business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Technology or R&D, Others
Revenue model
- Consulting Services: Strategic and technical consulting services delivered directly by senior Partners or Associates across all aspects of the product life-cycle including technical services, project management, and strategic planning.
- GMP Training Programs: Essential GMP Uplift and Advanced GMP Uplift training programs delivered online and in-person at GMP-like facilities. Programs include certification and digital credentials upon completion. Funded in part by MTPConnect REDI initiative.
- Translation Uplift Training: Online learning program covering product realization from R&D through to commercial supply, with short courses on Product Development, Process Scale-Up, Technology Transfer, Phase Appropriate GMPs, Supply Chain Management, and Process Validation.
- Tailored Training Programs: Customized training programs designed and delivered for Universities, Enterprises and Industry Associations, tailored to specific audience, subject matter and organizational needs.
Go-to-market motion1 record
Distribution channels5 records
Marketing channels7 records
CBE product offering
Product offeringCore offering
CBE provides specialist biopharmaceutical consulting services across the product life-cycle, including GxP compliance and audit support, regulatory and clinical strategy, due diligence, product and process robustness, facility and cleanroom design, and strategic consulting operations. The company also delivers structured training programs (Essential GMP Uplift, Advanced GMP Uplift, Translation Uplift, and Tailored Training) covering GMP, QMS, regulatory compliance, validation, and cleanroom operations. All consulting is delivered directly by senior Partners or Associates, and training combines online learning with hands-on sessions at GMP-like facilities.
Product overview
CBE (Centre for Biopharmaceutical Excellence) is a consulting firm offering specialist biopharmaceutical consultancy services and professional training programs across the Asia Pacific region. The company's portfolio consists of multiple training programs (Essential GMP Uplift, Advanced GMP Uplift, Translation Uplift, and Tailored Training) and consulting services (GxP Compliance, Regulatory and Clinical, Due Diligence, Product and Process Robustness, Facility Concept and Cleanroom Design, Consulting Operations and Strategy, and Courses and Training). The Essential and Advanced GMP Uplift Programs were developed under MTPConnect's REDI initiative to address skills gaps in the Australian MTP sector, while the Translation Uplift program covers product development from R&D through to commercial launch.
Differentiator
Problem solved
Functional benefit
Products and services
- Essential GMP Uplift Program Entry-level GMP training program designed for industry new starts up to 12 months in role, available as a 2-day online-only or 5-day combined online and face-to-face format covering core GMP principles. For biopharma, pharma, and MedTech personnel entering GMP-regulated roles.
- Advanced GMP Uplift Program In-depth GMP training program for experienced professionals (12+ months in GMP role) covering risk management, investigations and root cause analysis, validation, aseptic practices, audit readiness, and advanced QMS. For experienced biopharma and pharma personnel.
- Translation Uplift Program Online learning program covering product realisation from R&D through to commercial supply, with short courses on Product Development, Process Scale-Up, Technology Transfer, Phase Appropriate GMPs, Supply Chain Management, and Process Validation. For biopharma, pharma, and academic researchers involved in translational R&D.
- Tailored Training Customised training programs designed and delivered for Universities, Enterprises, and Industry Associations, tailored to specific audience, subject matter, and relevant issues with focus on practical, real-world experiences. For academic institutions, corporate clients, and industry bodies.
- Consulting Operations and Strategy Strategic consulting services including improvement programs, strategic plan development, corporate restructuring, divestments and acquisitions, project management, IT integration, commercialisation planning, and new product launch support. For biopharmaceutical companies seeking strategic and operational transformation support.
- GxP Compliance – Audits, Systems and Regulatory GxP regulatory compliance assessment, compliant GxP system design, non-compliant system remediation, regulatory inspection preparation, and regulatory finding resolution services. For biopharmaceutical and pharmaceutical companies needing GxP compliance support.
- Regulatory and Clinical Services Regulatory and clinical strategy advice, regulatory submission preparation, IND and BLA preparation, and meeting representation with regulators. For medical technology and biologics companies preparing regulatory submissions.
- Due Diligence Technical and scientific due diligence services ensuring technologies, facilities, manufacturing processes, quality systems and R&D portfolio align with commercial forecasts and assumptions. For investors, acquirers, and partners evaluating biopharma opportunities.
- Product and Process Robustness Consulting services to achieve robust manufacturing processes including process capability programs, technology transfer, scale-up, quality risk management, and control strategy development. For biopharmaceutical manufacturers seeking reliable, quality-assured commercial supply.
- Facility Concept and Cleanroom Design Concept design services, project delivery support, building and energy management, and facility compliance review for biologics (including ATMPs), sterile and non-sterile manufacturing, compounding facilities, research facilities, containment laboratories, complementary medicines, and advanced therapy facilities. For biopharmaceutical manufacturers building or qualifying GMP facilities.
- Courses and Training Industry-specific training programs covering Good Manufacturing Practices, Quality Management Systems, Regulatory Compliance, Validation, Facilities and cleanroom operations, Good Laboratory Practices, and Sterile manufacturing. For industry professionals across the biopharmaceutical sector.
Quantifiable outcome
- Participants from 85+ companies have completed GMP Uplift training programs
- +1 more outcomes
Companies that use CBE
Customer profileNamed customers8 records
Segments6 records
Ideal customer profiles3 records
CBE technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
CBE partnerships and signals
Strategic signalPartnerships
Ten partnerships are on record, tiered core, major and minor.
- ARCS AustraliacorePart of the CBE GMP Uplift Consortia. ARCS Australia brings strong connection with large Pharma and MedTech companies operating in Australia, LMS and virtual Community engagement infrastructure, and experience in developing, organising, hosting and administering educational training content.
- Merck Life Sciences AustraliacorePart of the CBE GMP Uplift Consortia. Merck brings significant hands-on experience in quality control methodology, particularly around biologics and microbiology technology, leading the quality control hands-on component of the training course.
- CBE Pure SolutionscorePart of the CBE GMP Uplift Consortia. CBE Pure Solutions brings an advanced specialist hands-on facility specifically designed for teaching GMP skills in Melbourne, VIC.
- Translational Research Institute (TRI) T3 CleanroomscorePart of the CBE GMP Uplift Consortia. TRI T3 Cleanrooms provides state-of-the-art facility set up for biologics manufacture in Brisbane, QLD for hands-on GMP training.
- UTS Biologics Innovation Facility (BIF)corePart of the CBE GMP Uplift Consortia. UTS BIF provides a state-of-the-art dedicated GMP-ready biologics facility set up for pilot scale manufacture in Sydney, NSW.
- Hong Kong Pharmaceutical Manufacturers Association (HKPMA)coreHKPMA selected CBE to design and conduct Hong Kong's continuing professional development industry education program. Programs are underwritten by Hong Kong's Government and are crucial to its transition to international GMP standards.
- Chinese University of Hong Kong (CUHK)majorCBE designed and delivered Biopharmaceutical, Pharmacopoeia and Accreditation course for CUHK School of Biomedical Sciences. Course was delivered online due to COVID-19 restrictions, providing fundamental knowledge for future industry leaders and Authorised Persons.
- Hong Kong Institute of Biotechnology (HKIB)minorCBE partnered with HKIB for delivery of Pharmaceutical Statistics training in Hong Kong, part of the continued professional development program.
- SeqirusmajorCBE director Paul Fletcher served as Business Process, Data and Deployment Lead on Seqirus' global rollout of SAP & GLIMs IT systems, leading southern hemisphere implementation for one of the world's largest biopharmaceutical manufacturers.
- Hong Kong Pharmaceutical Manufacturers Association (HKPMA)minorCBE delivered 3-day Pharmaceutical Statistics training in association with HKPMA and Hong Kong Institute of Biotechnology, with hands-on industry case studies.
Scale indicators4 records
Recent moves9 records
Expansion highlights6 records
CBE competitors and assessment
Company assessmentBroad incumbents
- NSF International (Health Sciences): Global organization providing GMP consulting, training, and certification services to pharma and biopharma. Comparable training programs and consulting services, with broader global reach than CBE.
- Thermo Fisher Scientific (PPD): Global life sciences services organization offering regulatory affairs, GxP compliance consulting, and clinical services. Competes with CBE on larger APAC biopharma regulatory and compliance engagements.
- PharmaLex: Global provider of regulatory affairs, quality compliance, and pharmacovigilance consulting for biopharma. Direct overlap with CBE's regulatory and GxP compliance offerings, with broader international footprint.
- Charles River Laboratories: Global CRO/CDMO offering biopharmaceutical services including regulatory consulting and training-adjacent services. Much broader scale than CBE but competes for similar APAC biopharma compliance mandates.
- IQVIA: Global CRO and consulting firm with extensive regulatory, quality, and compliance practices serving biopharma. Larger scale and broader service portfolio than CBE but competes for similar regulatory consulting mandates.
Direct peers
- Voisin Consulting Life Sciences: Specialist regulatory and quality consulting firm serving biopharma, MedTech, and ATMP developers globally. Overlaps with CBE's regulatory affairs, clinical strategy, and GxP compliance offerings, with deeper international presence.
- CS Analytical: Specialist consultancy focused on GMP compliance, regulatory affairs, and validation services for pharmaceutical and biotech manufacturers. Comparable in size and senior-partner-led delivery model to CBE.
- Biopharma Group: UK-based specialist consultancy providing GMP compliance, validation, and regulatory consulting to biopharmaceutical manufacturers. Highly comparable to CBE in service mix (GxP compliance, cleanroom, process validation) though geographically focused on Europe.
- Concept Heidelberg (PDA Europe affiliate): European provider of GMP training, conferences, and consulting for the pharmaceutical industry. Comparable to CBE in offering GMP training programs with strong content library and senior-faculty delivery.
Emerging players
- ARCS Australia: Australian industry association for therapeutics professionals, delivering CPD programs and partnering with CBE in the GMP Uplift Consortia. Adjacent overlap in training delivery but association rather than pure consulting model.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks5 records
Key highlights6 records
Customer concentration
CBE social profiles
Digital presenceCBE financial estimates
Financial estimateRevenue estimate
Valuation estimate
CBE leadership team
Management profileNumber of profiles
Profiles8 records
CBE subsidiaries and ownership
Company hierarchySubsidiaries1 record
CBE funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
CBE M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about CBE
What does CBE do?
CBE provides specialist biopharmaceutical consulting services across the product life-cycle, including GxP compliance and audit support, regulatory and clinical strategy, due diligence, product and process robustness, facility and cleanroom design, and strategic consulting operations. The company also delivers structured training programs (Essential GMP Uplift, Advanced GMP Uplift, Translation Uplift, and Tailored Training) covering GMP, QMS, regulatory compliance, validation, and cleanroom operations. All consulting is delivered directly by senior Partners or Associates, and training combines online learning with hands-on sessions at GMP-like facilities.
Is CBE a public or private company?
CBE is a private company. It is classified as management employee owned and is currently operating.
When was CBE founded?
CBE was founded in 2014. It employs 1 to 10 people.
Where is CBE based?
CBE is headquartered in Melbourne, Australia, in the Oceania region.
How does CBE make money?
Four revenue lines are on record. Consulting Services are the primary driver. The others are GMP Training Programs, translation Uplift Training and tailored Training Programs.
Who are CBE's main competitors?
Broad incumbents on record are NSF International (Health Sciences), Thermo Fisher Scientific (PPD), PharmaLex, Charles River Laboratories and IQVIA. Direct peers are Voisin Consulting Life Sciences, CS Analytical, Biopharma Group and Concept Heidelberg (PDA Europe affiliate). ARCS Australia is listed as an emerging player.
Does CBE have an API?
No public API is recorded for CBE.
What industry is CBE in?
CBE's product category is Biopharmaceutical Consulting Services. Its primary akta.pro industry code is HLAGAKAM, Training & Competency Programs for GxP Compliance, with a secondary code of HLAGAOAK, CMC, Process Development & Tech Transfer Staffing FSP. Its NAICS code is 54161 and its SIC code is 8742.